NextGen ALL risk stratification gene panel- T-ALL
NextGen ALL Risk Stratification Gene Panel by NGS - T-ALL, EDTA Bone Marrow** Price
Brief Details
What is a NextGen ALL Risk Stratification Gene Panel T ALL?
The NextGen ALL Risk Stratification Gene Panel for T ALL is a highly advanced genetic test for patients already diagnosed with T-cell Acute Lymphoblastic Leukaemia (T-ALL). This sophisticated test uses Next Generation Sequencing (NGS) technology to examine specific changes (mutations) in the DNA of cancer cells. It helps doctors understand how aggressive your cancer is and plan the most effective treatment approach tailored specifically for your health condition.
This test helps detect genetic mutations within cancer cells and classify the disease into different risk groups, which predicts the likelihood of cancer returning after treatment.
What does the NextGen ALL Risk Stratification Gene Panel T ALL measure?
This specialised panel creates a detailed genetic map of your T-ALL cancer cells to guide personalised treatment decisions:
- Specific gene mutations - Checks for alterations in carefully selected genes known to be important in T-ALL.
- Genetic subtype identification - Helps identify the precise subtype of T-ALL based on its unique genetic signature.
- Risk of relapse assessment - Classifies your cancer into risk categories such as standard-risk or high-risk.
- Treatment target identification - Sometimes identifies specific mutations that can be targeted with newer, specialised drugs.
- Therapy response prediction - Helps predict how well you might respond to different treatment approaches.
NextGen ALL Risk Stratification Gene Panel T ALL: Who Needs It and Why It's Done
What Symptoms May Call for a NextGen ALL Risk Stratification Gene Panel T ALL?
It's important to understand that this NGS sequencing panel is not ordered based on initial symptoms. It is only requested after a patient has been diagnosed with T-ALL. The initial diagnosis of T-ALL is typically made based on these symptoms:
- Persistent fever and frequent infections
- Extreme fatigue, weakness, and looking very pale due to anaemia
- Easy bruising or bleeding, including nosebleeds or bleeding gums
- Bone or joint pain that doesn't go away
- Swollen lymph nodes in the neck, underarms, or groin
- Shortness of breath during normal activities
Who should get a NextGen ALL Risk Stratification Gene Panel T ALL?
This highly specialised test is intended for a very specific group of patients:
- Patients with confirmed new diagnosis of T-cell acute lymphoblastic leukaemia (T-ALL), including children, adolescents, and adults.
- Patients requiring precise risk stratification for treatment planning.
- Individuals whose doctors need detailed genetic information to determine the most appropriate therapy approach.
Why is a NextGen ALL Risk Stratification Gene Panel T ALL done?
This test is performed to personalise cancer treatment for each individual patient. It helps doctors decide how intensive the chemotherapy should be, reducing the risk of both under-treating aggressive cancer and overtreating less aggressive forms.
Importance of a NextGen ALL Risk Stratification Gene Panel T ALL
This test represents a significant advancement in personalised cancer care, moving beyond traditional risk assessment methods to provide precise genetic insights. Previously, risk stratification relied mainly on factors like age and white blood cell count at diagnosis, but this genetic panel adds crucial molecular-level information.
The test helps refine treatment decisions by identifying patients who might benefit from more intensive therapy or, conversely, those who could receive less intensive treatment to minimise long-term side effects. For high-risk patients, results can help determine if a bone marrow transplant is needed for the best chance of cure. This precision approach is particularly valuable for children, as it helps reduce long-term treatment-related complications while maximising therapeutic effectiveness.
NextGen ALL Risk Stratification Gene Panel T ALL Booking & Reports – Metropolis Healthcare India
How to Book a NextGen ALL Risk Stratification Gene Panel T ALL?
- Simple Online Booking
Booking can be done through the Metropolis Healthcare App or website. Select NextGen ALL Risk Stratification Gene Panel T ALL, choose a convenient time slot, and visit the nearest Metropolis Lab.
- Sample Tracking Updates
Stay informed at every step. From collection to testing, you can track your sample directly through the Metropolis Healthcare website.
- Accurate Laboratory Testing
Your sample is processed at our NABL & CAP accredited laboratories, where expert technicians ensure accurate results.
- Quick & Easy Reports
Receive your test reports promptly via email, WhatsApp, or by downloading them directly from the Metropolis Healthcare website or app.
Is home sample collection for NextGen ALL Risk Stratification Gene Panel T ALL available near you?
No, Metropolis Healthcare does not provide home sample collection for NextGen ALL Risk Stratification Gene Panel T ALL. This specialised test requires bone marrow sample collection, which must be performed at a hospital or medical facility by trained specialists. Our team coordinates with your healthcare provider to ensure seamless sample processing and accurate results.
How Long Does It Take to Get a NextGen ALL Risk Stratification Gene Panel T ALL Report?
Reports are usually available after 5 days once the sample reaches the lab.
Note: Reporting time may vary depending on your location.
Where can I see or get NextGen ALL Risk Stratification Gene Panel T ALL results?
Test results from Metropolis Healthcare can be accessed through multiple convenient channels. You can log in to the Metropolis website using your credentials or use the Metropolis Healthcare App to view and download your reports. Additionally, test reports are sent via email or WhatsApp and you also have the option to collect a physical copy directly from the lab.
Interpreting NextGen ALL Risk Stratification Gene Panel T ALL Results
What Your NextGen ALL Risk Stratification Gene Panel T ALL Results May Indicate
The following table explains how your genetic test results are interpreted to guide your treatment decisions:
|
Parameters |
Result Type |
Clinical Significance |
|
NRAS Gene |
Mutation Detected/Not Detected |
When mutated, indicates higher risk of treatment resistance and relapse |
|
Gene Fusions (RUNX1, MLLT10) |
Fusion Present/Absent |
Presence indicates specific leukaemia subtype requiring targeted treatment |
|
PHF6 Gene |
Mutation Detected/Not Detected |
Mutations associated with T-ALL development and progression |
|
Variant Allele Frequency |
Variable (reported as %) |
Higher percentages indicate greater proportion of cancer cells carrying the mutation, lower percentages may indicate minimal disease burden |
Conditions that May Affect NextGen ALL Risk Stratification Gene Panel T ALL Accuracy
Several factors can influence the accuracy of your genetic test results and should be discussed with your healthcare team:
- Sample quality - Insufficient bone marrow sample or blood contamination may affect results.
- Previous treatments - Chemotherapy or radiation therapy may alter the genetic profile of cancer cells.
- Sample handling - Improper storage or transportation conditions can degrade genetic material.
- Clotted samples - Blood clotting in the sample container can interfere with genetic analysis.
- Low tumour burden - Very few blood cancer cells in the sample may make detection difficult.
- Technical limitations - Certain genetic regions may be challenging to sequence accurately.
How is a NextGen ALL Risk Stratification Gene Panel T ALL Done?
The NextGen ALL Risk Stratification Gene Panel follows a sophisticated multi-step process:
- Sample collection - A bone marrow sample is obtained through aspiration and biopsy, typically from the hip bone under local anaesthesia.
- DNA and RNA extraction - Genetic material is carefully isolated from the bone marrow cells and quantified using specialised equipment.
- Target amplification - Specific genes of interest are amplified to ensure adequate material for analysis.
- Library preparation - The amplified genetic material undergoes adapter ligation and barcoding for identification.
- Next-generation sequencing - The prepared sample is processed using advanced Ion S5 sequencing technology.
- Data analysis - Sophisticated software aligns sequences to the human reference genome and identifies genetic variants.
- Clinical interpretation - Expert pathologists analyse the results and classify variants according to established medical guidelines.
How Should You Prepare for a NextGen ALL Risk Stratification Gene Panel T ALL?
Preparation for this test focuses primarily on the bone marrow biopsy procedure:
- No fasting required - No special diet or fasting is required for the pathology lab test. However, if sedation is planned for the bone marrow biopsy, you may need to fast beforehand as suggested by your doctor.
- Medication review - Inform your doctor about all medications, especially blood thinners like aspirin or warfarin, which may need temporary discontinuation.
- Bring clinical history - Ensure your complete medical records and histopathology reports are available.
- Arrange transportation - Plan for someone to drive you home if sedation is used during the procedure.
- Comfortable clothing - Wear loose, comfortable clothing that allows easy access to the biopsy site.
Diseases that a NextGen ALL Risk Stratification Gene Panel T ALL Can Help Detect
This specialised genetic panel provides crucial information for managing T-cell acute lymphoblastic leukaemia:
- High-risk T-ALL subtypes - Identifies aggressive forms that require intensive treatment.
- Treatment-resistant variants - Detects genetic changes associated with chemotherapy resistance.
- Relapse risk assessment - Helps predict likelihood of cancer returning after treatment.
- Minimal residual disease - Can assist in monitoring treatment response.
- Secondary malignancies - May identify genetic predisposition to other cancers.
- Targeted therapy candidates - Identifies patients who may benefit from specific targeted treatments.
NextGen ALL Risk Stratification Gene Panel T ALL/Packages that You Can Book With Metropolis Healthcare
Metropolis Healthcare offers comprehensive leukaemia testing options to support your cancer diagnosis and management:
|
Test/Package Name |
Purpose/Highlights |
|
Comprehensive genetic analysis of acute leukaemia from bone marrow samples |
|
|
Blood-based genetic testing for acute leukaemia diagnosis and monitoring |
|
|
Fluorescence in-situ hybridisation testing for specific chromosomal abnormalities in ALL |
Frequently asked questions
Find quick answers to the most common questions about health tests, bookings, and reports.
Regular exercise, a balanced diet, avoiding smoking, maintaining a healthy weight, and managing stress all help reduce heart disease risk.
Common signs include irritability, trouble sleeping, headaches, difficulty concentrating, and muscle tension.
Ratings & Reviews
We're satisfying our customers every day since 1980.
Choose precision On time, every time!
- 98% on time collections with a 60 minutes promise
- Real-time tracking of phlebotomist arrival and report generation
- Fully digital report delivery—view from mobile or desktop instantly
- Continuous monitoring of turnaround times to ensure accuracy and speed
- Dedicated support team to resolve any delays or queries quickly
Why Metropolis Healthcare?
Metropolis has been present for over 40 years in the market.
Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.
0
Years of experience
170+
Advanced Labs
Trusted by
Leading Doctors & Hospitals
2,000+
Scientific Officers
Proficiency Testing
for Accurate Reports
Latest Blogs & News
Stay informed with our expert insights and updates.
About Us
Metropolis Healthcare is a leading diagnostic service provider in India. We are a team of dedicated professionals committed to ensuring you and your family receive the most accurate and timely healthcare solutions. We believe in making health care accessible, affordable and evidence-based. Our expert panel are equipped with the latest technology and manned by a certified team of over 4000+ technicians.
In diagnostic services, we have more than three decades of experience servicing diverse stakeholders health advantage packages for men, women and seniors, genetic fitness & corporation in over 650+ tests like Oncology, Neurology, Gynaecology, Haematology, and many more. Our diagnostic services are located in leading doctors and clinics and serve over 15+ cities in India.